Literature DB >> 10727406

Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.

J J Schuringa1, L J Jonk, W H Dokter, E Vellenga, W Kruijer.   

Abstract

In the present study, signal transducer and activator of transcription 3 (STAT3) Ser(727) phosphorylation and transactivation was investigated in relation to activation of mitogen-activated protein (MAP) kinase family members including extracellular-signal-regulated protein kinase (ERK)-1, c-Jun N-terminal kinase (JNK)-1 and p38 ('reactivating kinase') in response to interleukin (IL)-6 stimulation. Although IL-6 can activate ERK-1 in HepG2 cells, STAT3 transactivation and Ser(727) phosphorylation were not reduced by using the MAP kinase/ERK kinase (MEK) inhibitor PD98059 or by overexpression of dominant-negative Raf. IL-6 did not activate JNK-1 in HepG2 cells and STAT3 was a poor substrate for JNK-1 activated by anisomycin, excluding a role for JNK1 in IL-6-induced STAT3 activation. However, SEK-1/MKK-4 [where SEK-1 stands for stress-activated protein kinase (SAPK)/ERK kinase 1, and MKK-4 stands for MAP kinase kinase 4] was activated in response to IL-6 and overexpression of dominant-negative SEK-1/MKK-4(A-L) reduced both IL-6-induced STAT3 Ser(727) phosphorylation as well as STAT3 transactivation. Subsequently, the SEK-1/MKK-4 upstream components Vav, Rac-1 and MEKK were identified as components of a signal transduction cascade that leads to STAT3 transactivation in response to IL-6 stimulation. Furthermore, inhibition of p38 kinase activity with the inhibitor SB203580 did not block STAT3 Ser(727) phosphorylation but rather increased both basal as well as IL-6-induced STAT3 transactivation, indicating that p38 may act as a negative regulator of IL-6-induced STAT3 transactivation through a presently unknown mechanism. In conclusion, these data indicate that IL-6-induced STAT3 transactivation and Ser(727) phosphorylation is independent of ERK-1 or JNK-1 activity, but involves a gp130 receptor-signalling cascade that includes Vav, Rac-1, MEKK and SEK-1/MKK-4 as signal transduction components.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727406      PMCID: PMC1220935     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK.

Authors:  K W Wood; C Sarnecki; T M Roberts; J Blenis
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

2.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.

Authors:  D P Gearing; M R Comeau; D J Friend; S D Gimpel; C J Thut; J McGourty; K K Brasher; J A King; S Gillis; B Mosley
Journal:  Science       Date:  1992-03-13       Impact factor: 47.728

3.  Mechanism of activation of the vav protooncogene.

Authors:  J Coppola; S Bryant; T Koda; D Conway; M Barbacid
Journal:  Cell Growth Differ       Date:  1991-02

4.  CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130.

Authors:  N Y Ip; S H Nye; T G Boulton; S Davis; T Taga; Y Li; S J Birren; K Yasukawa; T Kishimoto; D J Anderson
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

5.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.

Authors:  P Crespo; K E Schuebel; A A Ostrom; J S Gutkind; X R Bustelo
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

6.  An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control.

Authors:  T G Boulton; G D Yancopoulos; J S Gregory; C Slaughter; C Moomaw; J Hsu; M H Cobb
Journal:  Science       Date:  1990-07-06       Impact factor: 47.728

7.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases.

Authors:  R H Chen; C Sarnecki; J Blenis
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases.

Authors:  F A Gonzalez; D L Raden; R J Davis
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

9.  Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro.

Authors:  P Dent; W Haser; T A Haystead; L A Vincent; T M Roberts; T W Sturgill
Journal:  Science       Date:  1992-09-04       Impact factor: 47.728

10.  Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity.

Authors:  A Lin; J Frost; T Deng; T Smeal; N al-Alawi; U Kikkawa; T Hunter; D Brenner; M Karin
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

View more
  24 in total

Review 1.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

Review 2.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

Authors:  Lerin R Luckett-Chastain; Michael A Ihnat; Bethany M Mickle-Kawar; Randle Michael Gallucci
Journal:  J Interferon Cytokine Res       Date:  2012-02-07       Impact factor: 2.607

4.  Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells.

Authors:  Haiyun Sun; Yingnan Zhang; Ping Gao; Qiang Li; Yuqian Sun; Jinchao Zhang; Changqing Xu
Journal:  Mol Cell Biochem       Date:  2010-10-27       Impact factor: 3.396

5.  Rac1 mediates STAT3 activation by autocrine IL-6.

Authors:  T R Faruqi; D Gomez; X R Bustelo; D Bar-Sagi; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

6.  Interleukin 6 protects pancreatic β cells from apoptosis by stimulation of autophagy.

Authors:  Amelia K Linnemann; Joseph Blumer; Michelle R Marasco; Therese J Battiola; Heidi M Umhoefer; Jee Young Han; Dudley W Lamming; Dawn Belt Davis
Journal:  FASEB J       Date:  2017-06-07       Impact factor: 5.191

7.  Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression.

Authors:  P Kovarik; M Mangold; K Ramsauer; H Heidari; R Steinborn; A Zotter; D E Levy; M Müller; T Decker
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

8.  A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eleni Kyratzopoulou; Dionysios A Giannimaras; Stefania Sarno; George Simos; Urania Georgopoulou; Avgi Mamalaki
Journal:  Cell Mol Life Sci       Date:  2014-04-10       Impact factor: 9.261

Review 9.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA.

Authors:  Salvador Aznar Benitah; Pilar F Valerón; Hallgeir Rui; Juan Carlos Lacal
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.